NCT04556214
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Oslo University Hospital Oslo, Norway
Clinical trial condition
Cholangiocarcinoma
Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
490 public trials
154 recruiting studies
Cholangiocarcinoma trial results
NCT04078230
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- The Johns Hopkins Hospital Baltimore, Maryland, United States
- China-Japan Friendship Hospital Beijing, Beijing Municipality, China
- Chinese PLA General Hospital Beijing, Beijing Municipality, China
- Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University Guangzhou, Guangdong, China
Recruiting
Deep Liver Phenotyping and Immunology Study
NCT04946773
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- John Radcliffe Hospital Oxford, Oxfordshire, United Kingdom
Recruiting
Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
NCT05184400
- Conditions
- Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
- Locations
-
- Herlev & Gentofte Hospital Herlev, Copenhagen, Denmark
Enrolling by Invitation
Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)
NCT06474091
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Enrolling by Invitation
Analysis of the Incidence of Cholangiocarcinoma on Choledochal Cyst in a Western Center
NCT05404503
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, +14 more
- Locations
-
- Juan Ramón Jimenez Hospital Huelva, Spain
Enrolling by Invitation
Adjuvant Immunotherapy Combined With ChemoRadiation for Patients With High-risk Resectable Extrahepatic Cholangiocarcinoma（AICRC）
NCT06997913
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +11 more
- Locations
-
- Department of Hepatobiliary Surgery, the First Affiliated Hospital of Air Force Military Medical University XiAn, Shanxi, China
Enrolling by Invitation
Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT)
NCT06963060
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
- Locations
-
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
Enrolling by Invitation
Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
NCT06901622
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, China
Enrolling by Invitation
The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells
NCT01868490
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +10 more
- Locations
-
- Siriraj Clinical Research Center, Siriraj Hospital Bangkoknoi, Bangkok, Thailand
- Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok, Thailand